StockIQpro
NASDAQ:TVGN

Tevogen Inc.

Tevogen Inc. reported net income of −$26.3M in fiscal 2025. Free cash flow was −$12.4M, and the diluted share count rose 13.2%.Summary generated from Tevogen Inc.'s SEC filings. Latest annual report filed Mar 31, 2026.

Revenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equityn/a
Debt / equityn/a
Free cash flow−$12.4M
FCF marginn/a
Share count change+13.2%

Financials

Fiscal years, $M
Item2022202320242025
Revenuen/an/an/an/a
Operating incomen/a−9−54−26
Net income4−60−14−26
Free cash flown/a−8n/a−12

Recent filings

From SEC EDGAR

Peers

Biological products, (no diagnostic substances)